Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP4901 in Benign Prostatic Hyperplasia
NCT02038868Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP4901 in benign prostatic hyperplasia (BPH), sponsored by Astellas Pharma. Started Jul 2013; status: completed.
02
Drugs
ASP4901
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02038868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038868.